Phibro Animal Health Maintains FY2027 Adjusted EPS Outlook at $3.41-$3.59
Bitget2026/11/05 16:24- Phibro Animal Health maintained fiscal 2027 net sales guidance of $1.55 billion to $1.6 billion on November 5, 2026.
- Adjusted EBITDA is forecast at $258 million to $268 million.
- Adjusted EPS guidance remains $3.41 to $3.59; GAAP EPS is projected at $2.98 to $3.22.
- First-quarter sales rose 6% to $386.8 million; adjusted EBITDA increased 4% to $64.3 million.
- The outlook assumes no additional virginiamycin sales in Brazil following the transition period's expiration at the end of October.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
After acquiring SpotHero, Uber (UBER.US) makes its debut in the parking sector with a parking space reservation feature, initially available in 15 U.S. cities
Uber has launched a brand new parking space reservation feature, which marks its first step in the parking sector following its acquisition of the parking app SpotHero earlier this year.
Arbitrum will welcome a new propAMM
Domestic sales "underperform," PepsiCo (PEP.US) launches mass layoffs of thousands in North America
PepsiCo North America has cut about 1,000 jobs to streamline operations, as beverage sales in the third quarter fell by 2% year-on-year and the full-year profit outlook has been revised downward.
WLFI: Token buyback will be carried out on Aster through a public wallet
Crypto prices
More
